Due to the multifocal nature of PCa, tumor foci can be found with and without a TMPRSS2:ERG in individual prostates [58] such that they are present in ~70% of cancerous prostates [59], making them a more useful biomarker than was originally apparent. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.